January 10, 2019
Rose
“If we don’t do this as an industry, I think there will be other alternatives that will be more onerous for us,” Johnson & Johnson CEO Alex Gorsky said at the J.P. Morgan Healthcare Conference in California. Drug pricing was just one of the many topics that were being hotly discussed at the annual event that draws the movers-and-shakers in the industry.
from Kaiser Health News http://bit.ly/2M58tzq
January 10, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Abortion Battles Expected To Heat Up In 2019: Get A Primer On Emerging Scenarios- UN Overwhelmingly Blocks U.S. Attempt To Strip Resolution Of References To ‘Sexual And Reproductive Health’
- The Church Of Safe Injection: Advocates Handing Out Naloxone, Syringes Find Legal Loophole In Religious Protections
- Care At Veterans Hospitals Is Just As Good Or Better As Local Private Hospitals, New Study Reports
- There’s A Nearly Fourfold Increase In Child Abuse On Saturdays When Report Cards Are Released On Fridays
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment